SCHEMBL295344

SCHEMBL295344

O=CC(=O)c1ccccc1F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.62
CES1 P23141 3/20 0.62
ALDH1A1 P00352 4/20 0.58
ALOX15 P16050 1/20 0.58
GAA P10253 1/20 0.57
GPR52 Q9Y2T5 1/20 0.51
TDP1 Q9NUW8 2/20 0.50
MAPK1 P28482 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TSHR P16473 1/20 0.50
MAPT P10636 2/20 0.48
NPC1 O15118 2/20 0.48
HPGD P15428 2/20 0.48
PTPN1 P18031 1/20 0.47
ERCC5 P28715 1/20 0.47
FEN1 P39748 1/20 0.47
BCHE P06276 1/20 0.46
MAOB P27338 1/20 0.46
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL29955657 0.98 CES2 (0.60) CES2CES1ALDH1A1ALOX15GAA
Water SCHEMBL9329581 0.98 CES2 (0.60) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL420969 0.85 ALDH1A1 (0.59) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL2650858 0.83 CES2 (0.50) CES2CES1ALDH1A1ALOX15GAA
Water SCHEMBL28342642 0.83 CES2 (0.61) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL118109 0.82 CES2 (0.58) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL9211931 0.82 CES2 (0.58) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL30634467 0.82 CES2 (0.58) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL27201537 0.81 CES2 (0.47) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL4888097 0.79 CES2 (0.54) CES2CES1ALDH1A1ALOX15GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2011526813-A 2011-10-20 JP claimed
EP-2310068-A2 NANOCLAY SORBENTS FOR DIALYSIS DEVICE Baxter International Inc. (US) 2011-04-20 EP claimed
US-20100004588-A1 NANOCLAY SORBENTS FOR DIALYSIS BAXTER INTERNATIONAL INC. (US) 2010-01-07 US claimed
WO-2010002830-A2 NANOCLAY SORBENTS FOR DIALYSIS DEVICE BAXTER INTERNATIONAL INC. (US) 2010-01-07 WO claimed
WO-2024210572-A1 NOVEL IMIDAZOLE DERIVATIVE AND USE THEREOF 주식회사 펠레메드 2024-10-10 WO disclosed
WO-2023094594-A1 SUBSTITUTED DIHYDROPYRANOPYRIDINES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2023-06-01 WO disclosed
WO-2023094594-A1 SUBSTITUTED DIHYDROPYRANOPYRIDINES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2023-06-01 WO disclosed
US-20210353840-A1 NANOCLAY SORBENT METHODS FOR USE WITH DIALYSIS VANTIVE US HEALTHCARE LLC 2021-11-18 US disclosed
US-20190262527-A1 NANOCLAY SORBENT METHODS FOR USE WITH DIALYSIS VANTIVE US HEALTHCARE LLC 2019-08-29 US disclosed
US-10342912-B2 Nanoclay sorbents for dialysis BAXTER INTERNATIONAL INC. (US) 2019-07-09 US disclosed
US-20180071446-A1 NANOCLAY SORBENTS FOR DIALYSIS VANTIVE HEALTH GMBH (CH) 2018-03-15 US disclosed
US-9821105-B2 Nanoclay sorbents for dialysis BAXTER INTERNATIONAL INC. (US) 2017-11-21 US disclosed
EP-2310068-B1 NANOCLAY SORBENTS FOR DIALYSIS DEVICE BAXTER INT (US) 2012-03-14 EP disclosed
EP-2310068-A2 NANOCLAY SORBENTS FOR DIALYSIS DEVICE Baxter International Inc. (US) 2011-04-20 EP disclosed
US-20100004588-A1 NANOCLAY SORBENTS FOR DIALYSIS BAXTER INTERNATIONAL INC. (US) 2010-01-07 US disclosed
WO-2010002830-A2 NANOCLAY SORBENTS FOR DIALYSIS DEVICE BAXTER INTERNATIONAL INC. (US) 2010-01-07 WO disclosed
US-5216170-A Promoters of livestock; treatment of obesity BAYER AKTIENGESELLSCHAFT (DE) 1993-06-01 US disclosed
US-5053509-A Microbiocides; AIDS LABORATOIRE ROGER BELLON (FR) 1991-10-01 US disclosed
US-5028617-A Heteroarylethanol-pyridylalkylamines for controlling animal growth BAYER AKTIENGESELLSCHAFT (DE) 1991-07-02 US disclosed
EP-0379928-A2 Aryl- and heteroarylethanol-pyridylalkylamines, process for their preparation and their use as performance stimulators by animals and as anti-adipositas agent BAYER AG (DE) 1990-08-01 EP disclosed